vs
Side-by-side financial comparison of Lulu's Fashion Lounge Holdings, Inc. (LVLU) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $66.1M, roughly 1.1× Lulu's Fashion Lounge Holdings, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -11.8%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-2.6M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -14.7%).
Lulu's Fashion Lounge Holdings, Inc. is a direct-to-consumer women's fashion retailer offering affordable, trendy apparel, footwear, and accessories. It primarily serves Gen Z and millennial consumers across North America, operating mainly via its e-commerce platform, with limited pop-up physical locations to boost customer engagement.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
LVLU vs PBYI — Head-to-Head
Income Statement — Q4 FY2024 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $66.1M | $75.5M |
| Net Profit | $-31.9M | — |
| Gross Margin | 37.9% | 69.3% |
| Operating Margin | -52.8% | 22.7% |
| Net Margin | -48.2% | — |
| Revenue YoY | -11.8% | 27.7% |
| Net Profit YoY | -340.9% | — |
| EPS (diluted) | $-13.46 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $75.5M | ||
| Q3 25 | — | $54.5M | ||
| Q2 25 | — | $52.4M | ||
| Q1 25 | — | $46.0M | ||
| Q4 24 | $66.1M | $59.1M | ||
| Q3 24 | $80.5M | $80.5M | ||
| Q2 24 | $92.0M | $47.1M | ||
| Q1 24 | $77.3M | $43.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | $8.8M | ||
| Q2 25 | — | $5.9M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | $-31.9M | — | ||
| Q3 24 | $-6.9M | $20.3M | ||
| Q2 24 | $-10.8M | $-4.5M | ||
| Q1 24 | $-5.7M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | 37.9% | 76.4% | ||
| Q3 24 | 38.1% | 63.9% | ||
| Q2 24 | 45.5% | 77.4% | ||
| Q1 24 | 42.3% | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | -52.8% | 22.6% | ||
| Q3 24 | -8.5% | 27.4% | ||
| Q2 24 | -4.9% | -4.6% | ||
| Q1 24 | -8.0% | -5.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 16.2% | ||
| Q2 25 | — | 11.2% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | -48.2% | — | ||
| Q3 24 | -8.5% | 25.2% | ||
| Q2 24 | -11.7% | -9.6% | ||
| Q1 24 | -7.4% | -11.0% |
| Q4 25 | — | $0.26 | ||
| Q3 25 | — | $0.17 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | $-13.46 | $0.40 | ||
| Q3 24 | $-2.47 | $0.41 | ||
| Q2 24 | $-3.92 | $-0.09 | ||
| Q1 24 | $-0.15 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.5M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $13.4M | $130.3M |
| Total Assets | $108.2M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | $4.5M | $101.0M | ||
| Q3 24 | $6.3M | $96.7M | ||
| Q2 24 | $1.8M | $96.8M | ||
| Q1 24 | $5.5M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | — | $130.3M | ||
| Q3 25 | — | $115.3M | ||
| Q2 25 | — | $104.7M | ||
| Q1 25 | — | $97.1M | ||
| Q4 24 | $13.4M | $92.1M | ||
| Q3 24 | $43.8M | $71.1M | ||
| Q2 24 | $48.7M | $48.5M | ||
| Q1 24 | $57.7M | $51.0M |
| Q4 25 | — | $216.3M | ||
| Q3 25 | — | $202.9M | ||
| Q2 25 | — | $194.9M | ||
| Q1 25 | — | $196.2M | ||
| Q4 24 | $108.2M | $213.3M | ||
| Q3 24 | $153.5M | $220.7M | ||
| Q2 24 | $145.3M | $205.0M | ||
| Q1 24 | $160.6M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $14.4M |
| Free Cash FlowOCF − Capex | $-2.6M | $14.4M |
| FCF MarginFCF / Revenue | -3.9% | 19.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.3M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | $-2.5M | $15.6M | ||
| Q3 24 | $-5.5M | $11.0M | ||
| Q2 24 | $3.7M | $1.0M | ||
| Q1 24 | $6.9M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | $-2.6M | $15.6M | ||
| Q3 24 | $-5.9M | $11.0M | ||
| Q2 24 | $3.4M | $1.0M | ||
| Q1 24 | $6.4M | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | -3.9% | 26.4% | ||
| Q3 24 | -7.3% | 13.7% | ||
| Q2 24 | 3.7% | 2.1% | ||
| Q1 24 | 8.3% | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.5% | 0.0% | ||
| Q2 24 | 0.4% | 0.0% | ||
| Q1 24 | 0.7% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LVLU
| Single Reportable Segment | $63.0M | 95% |
| Other | $2.4M | 4% |
| Stored Value Cards | $750.0K | 1% |
PBYI
Segment breakdown not available.